George D Demetri Selected Research

George D Demetri Research Topics

Disease

98	Neoplasms (Cancer) 05/2022 - 01/2002
61	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2021 - 01/2002
43	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 02/2002
22	Disease Progression 01/2021 - 10/2002
14	Liposarcoma 12/2019 - 09/2002
12	Leiomyosarcoma 12/2019 - 09/2009
11	Fatigue 01/2016 - 04/2002
8	Anemia 01/2017 - 02/2002
7	Nausea 01/2016 - 10/2006
7	Hypertension (High Blood Pressure) 08/2014 - 12/2007
7	Breast Neoplasms (Breast Cancer) 05/2008 - 03/2002
6	Thrombocytopenia (Thrombopenia) 01/2021 - 11/2002
6	Neutropenia 05/2015 - 05/2002
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2002
4	Neoplasm Metastasis (Metastasis) 01/2018 - 07/2012
4	Cardiotoxicity 01/2016 - 05/2002
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2015 - 08/2002
4	Renal Cell Carcinoma (Grawitz Tumor) 12/2012 - 11/2006
4	Lung Neoplasms (Lung Cancer) 03/2012 - 02/2002
3	Alveolar Soft Part Sarcoma 03/2016 - 12/2012
3	Vomiting 01/2016 - 06/2012
3	Genetic Translocation (Chromosomal Translocation) 07/2015 - 07/2007
3	Melanoma (Melanoma, Malignant) 09/2013 - 04/2008
3	Leukemia 10/2009 - 06/2003
3	Dermatofibrosarcoma 05/2008 - 02/2005
2	Rare Diseases (Rare Disease) 01/2022 - 09/2003
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2004
2	Synovial Sarcoma (Synovioma) 11/2019 - 10/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2018 - 11/2009
2	Clear Cell Sarcoma 07/2015 - 12/2012
2	Abdominal Pain (Pain, Abdominal) 05/2015 - 03/2009
2	Stomatitis 06/2014 - 07/2013
2	Diarrhea 06/2014 - 08/2002
2	Exanthema (Rash) 06/2014 - 07/2013
2	Weight Loss (Weight Reduction) 06/2014 - 05/2012
2	Myxoid Liposarcoma 11/2012 - 07/2007
2	Edema (Dropsy) 11/2012 - 08/2002
2	Alopecia (Baldness) 03/2012 - 05/2002
2	Aggressive Fibromatosis (Desmoid) 05/2008 - 03/2006

Drug/Important Bio-Agent (IBA)

58	Imatinib Mesylate (Gleevec)FDA Link 12/2019 - 08/2002
31	Phosphotransferases (Kinase)IBA 01/2022 - 01/2003
20	Sunitinib (Sutent)FDA Link 12/2019 - 11/2006
15	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2002
15	Pharmaceutical PreparationsIBA 01/2021 - 10/2002
14	TrabectedinIBA 01/2021 - 01/2002
10	Biological ProductsIBA 03/2020 - 06/2003
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2003
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 08/2002
7	Dacarbazine (DIC)FDA LinkGeneric 12/2019 - 03/2016
7	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016 - 12/2003
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021 - 09/2002
6	regorafenibIBA 01/2021 - 07/2012
6	AnthracyclinesIBA 01/2017 - 02/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2009
5	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015 - 02/2002
5	Oncogene Proteins (Oncogene Protein)IBA 11/2012 - 01/2003
4	tyrosine receptor (receptor, tyrosine)IBA 01/2019 - 07/2013
4	Erythropoietin FDA Link 01/2005 - 02/2002
4	Epoetin Alfa (Epogen)FDA Link 08/2002 - 01/2002
3	entrectinibIBA 05/2022 - 01/2021
3	TropomyosinIBA 01/2022 - 01/2018
3	larotrectinibIBA 03/2020 - 01/2018
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2017
3	Angiogenesis InhibitorsIBA 05/2012 - 09/2004
3	Tyrosine (L-Tyrosine)FDA Link 04/2012 - 04/2004
3	Sorafenib (BAY 43-9006)FDA Link 02/2012 - 02/2008
3	thiamine triphosphorate (TTP)IBA 07/2010 - 11/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2008 - 03/2002
3	Hemoglobins (Hemoglobin)IBA 01/2005 - 08/2002
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 03/2020
2	Gemcitabine FDA Link 01/2021 - 05/2007
2	Therapeutic UsesIBA 01/2020 - 06/2003
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2019 - 10/2019
2	pazopanib FDA Link 08/2019 - 05/2012
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 11/2012
2	eribulin FDA Link 10/2017 - 04/2016
2	Microphthalmia-Associated Transcription FactorIBA 07/2015 - 12/2012
2	CytokinesIBA 07/2015 - 11/2002
2	nilotinib FDA Link 05/2015 - 09/2009
2	Ifosfamide FDA LinkGeneric 05/2015 - 09/2009
2	Tumor Biomarkers (Tumor Markers)IBA 09/2014 - 06/2003
2	Small Interfering RNA (siRNA)IBA 09/2014 - 07/2013
2	Protein Isoforms (Isoforms)IBA 06/2014 - 12/2003
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2013 - 09/2006
2	TOR Serine-Threonine KinasesIBA 07/2013 - 01/2012
2	ridaforolimusIBA 07/2013 - 01/2012
2	Transaminases (Aminotransferases)IBA 06/2012 - 05/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2008 - 11/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2008 - 03/2003
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2007 - 06/2005
2	Semaxinib (SU5416)IBA 01/2005 - 09/2004
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2005 - 09/2004
2	Troglitazone (Rezulin)FDA Link 06/2003 - 09/2002

Therapy/Procedure

69	Therapeutics 01/2022 - 01/2002
25	Drug Therapy (Chemotherapy) 12/2019 - 01/2002
4	Intravenous Infusions 05/2015 - 10/2002
3	Immunotherapy 11/2019 - 01/2017
2	Aftercare (After-Treatment) 07/2012 - 05/2006
2	Radiotherapy 04/2012 - 01/2008
2	Adjuvant Chemotherapy 05/2008 - 03/2003